Connect to other sites within the UBM Medica Network
Incretin drugs, which offer ease of use, very little hypoglycemia, and no weight gain (or even weight loss) seem to be an ideal therapy. But 80% to 90% of patients don’t stay on them. Why not?
Lifestyle Measures Cut Cardiovascular Deaths in Prediabetes
Group-based lifestyle interventions have long-term effects on prevention of diabetes beyond the period of active intervention, this clinical trial shows.
Mediterranean Diet Reduces Diabetes, Inflammation
Two new studies show the heart-healthy benefits of this eating plan.
Diabetes and Restless Legs: How Do They Relate?
Test yourself on restless legs syndrome; germ cell tumors; statin use; autoimmune syndromes; and sleep apnea with this quiz.
Cognitive Changes In Diabetes Related to Proliferative Retinopathy
Increasing evidences associates adult type 1 diabetes with cognitive problems.
Respiratory Diagnoses Missed, Alzheimer Biomarkers, and More
In the news: respiratory disease underdiagnosed, Alzheimer biomarkers, Crohn disease microbiome, migraine device, sleep apnea and diabetes.
Obstructive Sleep Apnea Worsens Diabetes Control
The findings provide another good reason for those with OSA to wear a CPAP mask that helps ensure uninterrupted breathing throughout the night.
Diabetes Boosts Stroke Risk in Women, But Not Men
Diabetes appears to increase the risk of stroke in women, but not in men, a new study shows.
Challenging Case: A Patient with Hypoglycemia and High HbA1c
Hypoglycemia in type 2 diabetes patients can be the result of insulin or sulfonylureas.
Podcast: Bariatric Surgery Bests Medical Therapy Alone in Obese Patients with Diabetes
Bariatric surgery nearly cures type 2 diabetes—at least that’s what results of a new study, presented at the recent ACC meeting, seem to imply.
Podcast: Incretins for Type 2 Diabetes Mellitus (Part 2)
In his second podcast, Dr Louis Kuritzky discusses the classes of incretin-based therapies now available for patients with type 2 diabetes mellitus.
Podcast: Update on Incretins (Part 1)
Louis Kuritzky, MD, talks about this relatively new treatment option.